【ChiCTR2100048866】THE EFFECTS OF COVID-19 PANDEMIC ON EMERGENCY ANTERIOR ABDOMINAL WALL HERNIA SURGERY
ChiCTR2100048866
结束
/
/
/
2021-07-18
/
/
新型冠状病毒肺炎(COVID-19)
THE EFFECTS OF COVID-19 PANDEMIC ON EMERGENCY ANTERIOR ABDOMINAL WALL HERNIA SURGERY
THE EFFECTS OF COVID-19 PANDEMIC ON EMERGENCY ANTERIOR ABDOMINAL WALL HERNIA SURGERY: IS IT SAFE TO POSTPONE ELECTIVE HERNIA SURGERY IN THE PANDEMIC?
The aim of this study was to investigate the effects of COVID-19 infection on Emergency anteior abdominal wall hernia surgery by comparing the outcomes of patients who underwent during the pandemic with those who underwent the same surgery in the non-pandemic control period a year ago. Furthermore we aimed to share our precautions and experiences during the pandemic.
析因分组(即根据危险因素或暴露因素分组)
回顾性研究
No
No
No
/
66
/
2019-03-11
2021-01-25
/
All emergent anterior abdominal wall surgeries in control and pandeic periods;
请登录查看Emergency surgeries without primary anterior abdominal wall repair surgery were excluded from the study (For example: Repairing the incisional hernia of a patient who had ileus surgery);
请登录查看Ahmet Baris Dirim
/
Ahmet Baris Dirim的其他临床试验
土耳其Adana City Research and Training Hospital的其他临床试验
- THE EFFECTS OF COVID-19 PANDEMIC ON EMERGENCY ANTERIOR ABDOMINAL WALL HERNIA SURGERY
- THE ROLE OF Ca 19-9, Ca 72-4, CEA AND CHOLESTEROL LEVELS IN PREDICTING MALIGNANCY IN GALLBLADDER POLYPS.
- Does Coronavirus Disease 2019 (COVID-19) Pandemic cause a delay in the diagnosis of gastric cancer patients?- a single center study
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

